Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,1 USD | +1,64% | +39,01% | -0,64% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 17,64 mln. 16,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -15,89 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,35 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 13,25 mln. 12,39 mln. | Nettoliquiditeiten 2023 | 3,84 mln. 3,59 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,65
x | K/w-verhouding 2023 |
-1,53
x | Werknemers | 11 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | +1,64% | ||
1 week | +39,01% | ||
Lopende maand | +80,86% | ||
1 maand | +106,67% | ||
3 maanden | +51,96% | ||
6 maanden | +0,65% | ||
Lopend jaar | -0,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
14-06-24 | 3,1 | +1,64% | 5 335 |
13-06-24 | 3,05 | -7,58% | 18 667 |
12-06-24 | 3,3 | +5,10% | 44 726 |
11-06-24 | 3,14 | +24,60% | 84 692 |
10-06-24 | 2,52 | +13,00% | 70 958 |
uitgestelde koers Nasdaq, 14 juni 2024 om 17:13 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-0,64% | 36,65 mln. | |
+18,48% | 124 mld. | |
+18,25% | 111 mld. | |
-12,12% | 23,17 mld. | |
+5,07% | 22,94 mld. | |
-39,94% | 17,42 mld. | |
-10,17% | 17,42 mld. | |
-14,97% | 16,9 mld. | |
+2,65% | 13,71 mld. | |
+27,37% | 11,82 mld. |